Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lacy MQ et al. - The combination of pomalidomide and low-dose dexamethasone is extremely active in the treatment of relapsed multiple myeloma, including high response rates in patients refractory to other novel agents.

Today in Myeloproliferative Dz...keeping you current

The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan
British Journal of Haematology, 12/11/09

Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells
European Journal of Haematology, 12/11/09

The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome
Blood, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address